Moody's is concerned about Teva's debt and refinancing needs, Copaxone sales erosion, weak uptake of new drugs, and litigation risks.
Teva plunges again as Moody's revises outlook to negative - Globes
Read More
Bagikan Berita Ini
Home » IFTTT »
Top stories - Google News
» Teva plunges again as Moody's revises outlook to negative - Globes
Subscribe to:
Post Comments (Atom)
0 Response to "Teva plunges again as Moody's revises outlook to negative - Globes"
Post a Comment